Reduced RASSF10 levels further reveal a reduced survival of colon cancer (Figure 8j), head and neck cancer patients (Figure 8k), as well as liver cancer (Figure 8l), lung cancer (Figure 8m) and gastric cancer patients (Figure 8n). Here, RASSF10 is linked to lung cancer.